146 related articles for article (PubMed ID: 11276304)
1. Effect of physical training on sulfamethazine acetylation rate.
Abzalov RA; Nigmatullina RR; Khairullina GN; Garmonov SY; Shakirova LS; Evgen'ev MI
Bull Exp Biol Med; 2000 Dec; 130(12):1141-3. PubMed ID: 11276304
[TBL] [Abstract][Full Text] [Related]
2. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
[TBL] [Abstract][Full Text] [Related]
3. Acetylation phenotype in colorectal carcinoma.
Ilett KF; David BM; Detchon P; Castleden WM; Kwa R
Cancer Res; 1987 Mar; 47(5):1466-9. PubMed ID: 3815349
[TBL] [Abstract][Full Text] [Related]
4. N-acetylation phenotyping with sulfamethazine in an Iranian population.
Sardaş S; Lahijany B; Cok I; Karakaya AE
Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
[TBL] [Abstract][Full Text] [Related]
5. [Acetylation phenotype in Graves' disease].
Górnik W; Syrenicz A; Gawrońska-Szklarz B; Wójcicki J
Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):743-5. PubMed ID: 2641798
[TBL] [Abstract][Full Text] [Related]
6. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.
Ylitalo P; Hinkka H
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):548-53. PubMed ID: 4066079
[TBL] [Abstract][Full Text] [Related]
7. Effects of nocloprost (9 beta-chloro-16,16-dimethyl PG E2) on absorption and disposition of antipyrine and sulfamethazine in healthy volunteers.
Siegmund W; Zschiesche M; Franke G; Müller C; Amon I
Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):190-7. PubMed ID: 8500921
[TBL] [Abstract][Full Text] [Related]
8. Acetylation phenotype is not associated with breast cancer.
Ilett KF; Detchon P; Ingram DM; Castleden WM
Cancer Res; 1990 Oct; 50(20):6649-51. PubMed ID: 2208127
[TBL] [Abstract][Full Text] [Related]
9. [Acetylation processes in chronic alcoholics].
Kovalev IE; Kovalev EN; Seleznev NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):232-4. PubMed ID: 6711211
[TBL] [Abstract][Full Text] [Related]
10. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
11. Incidence of isoniazid acetylation phenotypes in North Indians.
Gupta RC; Nair CR; Jindal SK; Malik SK
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149
[TBL] [Abstract][Full Text] [Related]
12. [Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer].
Orzechowska-Juzwenko K; Wiela-Hojeńska A; Milejski P; Cieślińska A; Hudziec P; Adamska M
Przegl Lek; 1997; 54(2):103-6. PubMed ID: 9198818
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of acetylation phenotype in the protection of production personnel].
Evgen'ev MI; Garmonov SIu; Bagniuk VP; Maksudova SE; Kochergin AV
Med Tr Prom Ekol; 2002; (11):35-8. PubMed ID: 12520909
[TBL] [Abstract][Full Text] [Related]
14. Isoniazid acetylation metabolic ratio during maturation in children.
Pariente-Khayat A; Rey E; Gendrel D; Vauzelle-Kervroëdan F; Crémier O; d'Athis P; Badoual J; Olive G; Pons G
Clin Pharmacol Ther; 1997 Oct; 62(4):377-83. PubMed ID: 9357388
[TBL] [Abstract][Full Text] [Related]
15. Sulfadimidine kinetics in patients with various chronic liver diseases.
Horváth T; Past T; Par A; Kádas I; Jávor T
Pol J Pharmacol Pharm; 1988; 40(3):257-64. PubMed ID: 3241767
[TBL] [Abstract][Full Text] [Related]
16. [Acetylation phenotype in patients with lung cancer].
Cofta S; Lowicki Z; Młynarczyk W
Pneumonol Alergol Pol; 1995; 63(7-8):407-9. PubMed ID: 8520558
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
Augustynowicz-Kopeć E; Zwolska Z
Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
[TBL] [Abstract][Full Text] [Related]
18. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Leszek J; Rudzik J; Grotthus B
Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435
[TBL] [Abstract][Full Text] [Related]
19. Acetylation phenotype and skin complexion.
Rampen FH; van der Meeren HL; Stolk LM
Acta Derm Venereol; 1986; 66(4):334-6. PubMed ID: 2430405
[TBL] [Abstract][Full Text] [Related]
20. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
Lil'in ET; Korsunskaia MP; Meksin VA; Drozdov ES; Nazarov VV
Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
